Literature DB >> 29851437

Tuberculosis patients not covered by treatment in public health services: findings from India's National Family Health Survey 2015-16.

Geeta Pardeshi1, Andrea Deluca2, Sutapa Agarwal3, Jugal Kishore1.   

Abstract

OBJECTIVE: Half of the TB patients in India seek care from private providers resulting in incomplete notification, varied quality of care and out-of-pocket expenditure. The objective of this study was to describe the characteristics of TB patients who remain outside the coverage of treatment in public health services.
METHODS: Cross-sectional data from National Family Health Survey-4 (2015-16) were analysed using logistic regression analysis. TB treatment was the dependent variable. Sociodemographic factors and place where households generally seek treatment were independent variables.
RESULTS: Prevalence of self-reported TB was 308.17/100 000 population (95% CI: 309.44-310.55/100 000 population) and 38.8% (95% CI: 36.5-41.1%) of TB patients were outside care of public health services - 3.3% did not seek treatment and 35.3% accessed treatment from private sector. Factors associated with not seeking treatment were age <10 years [OR = 3.43; 95% CI (1.52-7.77); P = 0.00]; no/preschool education [OR = 1.82; 95% CI (1.10-3.34); P = 0.02]; poorest wealth index [OR = 1.86; 95% CI (1.01-3.34); P = 0.04] and household's general rejection of the public sector when seeking health care [OR = 1.69; 95% CI (1.69-2.26); P = 0.00]. Factors associated with seeking treatment from private providers were female sex [OR = 1.29; 95% CI (1.11-1.50); P = 0.001], younger age of the patient [OR = 2.39; 95% CI (1.62-3.53); P = 0.00], higher education [OR = 1.82; 95% CI (1.11-2.98); P = 0.02] and household's general rejection of the public sector when seeking health care [OR = 4.56; 95% CI (3.95-5.27); P = 0.00]. Patients from households reporting 'poor quality of care' as the reason for not generally preferring public health services were more likely (OR = 1.48, 95% CI = 1.19-1.65; P = 00) to access private treatment.
CONCLUSION: The study provides insights for efforts to involve the private health sector for accurate surveillance and patient groups requiring targeted interventions for linking them to the national programme.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990RNTCPzzm321990; RNTCP; notification; private health services; public health services; services de santé privés; services de santé publique; tuberculose; tuberculosis

Mesh:

Year:  2018        PMID: 29851437      PMCID: PMC6103844          DOI: 10.1111/tmi.13086

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  22 in total

1.  'Lost' smear-positive pulmonary tuberculosis cases: where are they and why did we lose them?

Authors:  S B Squire; A K Belaye; A Kashoti; F M L Salaniponi; C J F Mundy; S Theobald; J Kemp
Journal:  Int J Tuberc Lung Dis       Date:  2005-01       Impact factor: 2.373

2.  Risk factors associated with default among new smear positive TB patients treated under DOTS in India.

Authors:  Sophia Vijay; Prahlad Kumar; Lakbir Singh Chauhan; Balasangameshwara Hanumanthappa Vollepore; Unnikrishnan Pallikkara Kizhakkethil; Sumathi Govinda Rao
Journal:  PLoS One       Date:  2010-04-06       Impact factor: 3.240

3.  Initial default among sputum-positive pulmonary TB patients at a referral hospital in Uttarakhand, India.

Authors:  Darshan Mehra; Rajeev M Kaushik; Reshma Kaushik; Jagdish Rawat; Rajesh Kakkar
Journal:  Trans R Soc Trop Med Hyg       Date:  2013-09       Impact factor: 2.184

Review 4.  Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis.

Authors:  Peter MacPherson; Rein M G J Houben; Judith R Glynn; Elizabeth L Corbett; Katharina Kranzer
Journal:  Bull World Health Organ       Date:  2013-11-22       Impact factor: 9.408

5.  Private patient perceptions about a public programme; what do private Indian tuberculosis patients really feel about directly observed treatment?

Authors:  Lancelot M Pinto; Zarir F Udwadia
Journal:  BMC Public Health       Date:  2010-06-22       Impact factor: 3.295

6.  From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts.

Authors:  Srinath Satyanarayana; Sreenivas Achutan Nair; Sarabjit Singh Chadha; Roopa Shivashankar; Geetanjali Sharma; Subhash Yadav; Subrat Mohanty; Vishnuvardhan Kamineni; Nevin Charles Wilson; Anthony David Harries; Puneet Kumar Dewan
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

7.  Durations and Delays in Care Seeking, Diagnosis and Treatment Initiation in Uncomplicated Pulmonary Tuberculosis Patients in Mumbai, India.

Authors:  Nerges Mistry; Sheela Rangan; Yatin Dholakia; Eunice Lobo; Shimoni Shah; Akshaya Patil
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

8.  How Do Urban Indian Private Practitioners Diagnose and Treat Tuberculosis? A Cross-Sectional Study in Chennai.

Authors:  Liza Bronner Murrison; Ramya Ananthakrishnan; Sumanya Sukumar; Sheela Augustine; Nalini Krishnan; Madhukar Pai; David W Dowdy
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

Review 9.  Barriers to initiating tuberculosis treatment in sub-Saharan Africa: a systematic review focused on children and youth.

Authors:  Brittney J Sullivan; B Emily Esmaili; Coleen K Cunningham
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

10.  Use of standardised patients to assess antibiotic dispensing for tuberculosis by pharmacies in urban India: a cross-sectional study.

Authors:  Srinath Satyanarayana; Ada Kwan; Benjamin Daniels; Ramnath Subbaraman; Andrew McDowell; Sofi Bergkvist; Ranendra K Das; Veena Das; Jishnu Das; Madhukar Pai
Journal:  Lancet Infect Dis       Date:  2016-08-25       Impact factor: 25.071

View more
  2 in total

1.  How much do Indians pay for tuberculosis treatment? A cost analysis.

Authors:  P Sinha; M Carwile; A Bhargava; C Cintron; C Acuna-Villaorduna; S Lakshminarayan; A F Liu; N Kulatilaka; L Locks; N S Hochberg
Journal:  Public Health Action       Date:  2020-09-21

Review 2.  Closing gaps in the tuberculosis care cascade: an action-oriented research agenda.

Authors:  Ramnath Subbaraman; Tulip Jhaveri; Ruvandhi R Nathavitharana
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-01-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.